Picture of Smith & Nephew logo

SN. — Smith & Nephew Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Momentum

Relative Strength (%)
1m-0.42%
3m-5.06%
6m-22.8%
1yr-32.07%
Volume Change (%)
10d/3m+1.62%
Price vs... (%)
52w High-23.55%
50d MA+0.3%
200d MA-8.63%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)18.54
PEG Ratio (f)1.28
EPS Growth (f)16.9%
Dividend Yield (f)2.25%
Valuation (ttm)IndustryMarket
Price to Book Value2.86
Price to Tang. Book18.01
Price to Free Cashflow19.17
Price to Sales2.97
EV to EBITDA15.5

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.12%
Return on Equity10.75%
Operating Margin10.52%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue$m4,6694,7654,9045,1384,5605,240.325,557.55-0.32%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-25.29+28.83+1.96-2.78-23.66+19.99+16.9n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for SN.

What lies in store for the Smith & Nephew share price? background image

What lies in store for the Smith & Nephew share price?

Economic uncertainty remains a major concern in many industry sectors. For investors in well known companies like Smith & Nephew (LON:SN.), the question is: where will prices go from here? Smith & Nephew is part of an elite clu...

Are analysts upbeat on the outlook for Smith & Nephew? background image

Are analysts upbeat on the outlook for Smith & Nephew?

While the world continues to wrestle with the consequences of the Covid-19 pandemic, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as Smith & Nephew (LON:SN.).  Smith...

What analysts are saying about shares in Smith & Nephew background image

What analysts are saying about shares in Smith & Nephew

Analysts have been under intense pressure in recent months as they try to make sense of the impact of Covid-19 on companies like Smith & Nephew (LON:SN.). As one of just 200 shares in the UK market valued at more than £1.0 billion...

What analysts are saying about shares in Smith & Nephew background image

What analysts are saying about shares in Smith & Nephew

Analysts have been under intense pressure in recent months as they try to make sense of the impact of Covid-19 on companies like Smith & Nephew (LON:SN.). As one of just 200 shares in the UK market valued at more than £1.0 billion...

Which way now for the Smith & Nephew share price? background image

Which way now for the Smith & Nephew share price?

The Covid-19 crisis has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from here.  These qu...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Smith & Nephew EPS forecast chart

Profile Summary

Smith & Nephew plc is a medical technology company. The Company is engaged in designing and manufacturing technology. It supports healthcare professionals to return their patients to health and mobility by helping them to perform. It serves its customers through global franchises, which includes Orthopaedics, Sports Medicine and Ear, Nose and Throat (ENT) and Advanced Wound Management. The Orthopaedics includes a range of Hip and Knee Implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that allow surgeons, and Trauma products used to stabilize severe fractures and correct bone deformities. Its Sports Medicine and ENT businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a set of products to meet clinical needs, to help healthcare professionals reduce the human and economic consequences of wounds.

Directors

Last Annual
December 31st, 2020
Last Interim
July 3rd, 2021
Incorporated
February 17th, 1937
Public Since
August 13th, 1951
No. of Shareholders
14,511
No. of Employees
18,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
879,777,014

SN. Share Price Performance

Latest News for SN.

Upcoming Events for SN.

Full Year 2021 Smith & Nephew PLC Earnings Release

Smith & Nephew PLC Annual Shareholders Meeting

Q1 2022 Smith & Nephew PLC Trading Statement Release

Similar to SN.

Picture of Abingdon Health logo

Abingdon Health

gb flag iconLondon Stock Exchange

Picture of Advanced Medical Solutions logo

Advanced Medical Solutions

gb flag iconLondon Stock Exchange

Picture of Advanced Oncotherapy logo

Advanced Oncotherapy

gb flag iconLondon Stock Exchange

Picture of Angle logo

Angle

gb flag iconLondon Stock Exchange

Aptamer

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email